Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02850588 · ClinicalTrials.gov registry record
SVS VQI TransCarotid Revascularization Surveillance Project
A clinical trial of Carotid Artery Disease, sponsored by Society for Vascular Surgery Patient Safety Organization.
- Recruiting
- Registry status
- 60,000
- Enrollment target
- 1
- Study location
NCT02850588: Recruiting study of Carotid Artery Disease, sponsored by Society for Vascular Surgery Patient Safety Organization.
NCT02850588 is a study of Carotid Artery Disease that is actively recruiting participants, run by Society for Vascular Surgery Patient Safety Organization. The registered enrollment target is 60,000 participants, above the 1,733-participant average among 5 other Carotid Artery Disease trials with a reported enrollment target (3362% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02850588, a study of Carotid Artery Disease, is actively recruiting participants, sponsored by Society for Vascular Surgery Patient Safety Organization.
- RECRUITING
- Registry status
- 60,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The VQI TCAR Surveillance Project is designed to monitor the safety and effectiveness of stents placed directly into the carotid artery while reversing blood flow within the carotid artery to reduce stroke risk. It will compare this less-invasive surgical procedure with standard carotid endarterectomy in centers that participate in the Society for Vascular Surgery Vascular Quality Initiative.
Primary Outcome
Any death or stroke in the territory of the treated carotid artery within one year of the carotid artery treatment
Conditions Studied
Interventions
- PROCEDURE Transcarotid artery revascularization
- PROCEDURE Carotid endarterectomy
Study Locations (1)
Illinois
- Society for Vascular Surgery Patient Safety Organization - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60,000 participants |
| Start Date | 2016-11-01 |
| Est. Completion | 2027-12-31 |
What NCT02850588 shows while recruiting
NCT02850588 is an observational study that tracks outcomes without assigning an intervention. Its 60,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,733-participant average among 5 other Carotid Artery Disease trials with a reported enrollment target (3362% higher).
The record links to 1 condition, with Carotid Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Transcarotid artery revascularization is the first listed.
NCT02850588 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02850588 about?
NCT02850588 is a clinical study titled "SVS VQI TransCarotid Revascularization Surveillance Project". The VQI TCAR Surveillance Project is designed to monitor the safety and effectiveness of stents placed directly into the carotid artery while reversing blood flow within the carotid artery to reduce stroke risk. It will compare this less-invasive surgical procedure with standard carotid endarterecto...
What is the current status of trial NCT02850588?
This trial is currently recruiting. The enrollment target is 60,000 participants. The study started on 2016-11-01. Estimated completion is 2027-12-31.
What conditions does trial NCT02850588 study?
This clinical trial studies the following conditions: Carotid Artery Disease.
What interventions are being tested in trial NCT02850588?
The interventions under investigation include: Transcarotid artery revascularization (PROCEDURE), Carotid endarterectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02850588?
This trial is sponsored by Society for Vascular Surgery Patient Safety Organization, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02850588 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carotid Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Gore SCAFFOLD Clinical Study
COMPLETED · NA
-
CAPTURE 2 Post-Marketing Registry
COMPLETED
-
Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study
COMPLETED · NA
-
Assessment Of Vascular Health After Niacin Therapy (AVANT)
COMPLETED · NA
-
Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00785525 · 60,000 participants · Phase 3
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
- NCT01825499 · 60,000 participants
Vermont Oxford Network Very Low Birth Weight Database
- NCT03752840 · 60,200 participants · NA
Village-Integrated Eye Worker Trial II
- NCT05723614 · 61,770 participants · NA
TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI